North Star Investment Management Corp. Eli Lilly & CO Transaction History

North Star Investment Management Corp.

$1.35 Billion
Q2 2024

A detailed history of North Star Investment Management Corp. transactions in Eli Lilly & CO stock. As of the latest transaction made, North Star Investment Management Corp. holds 8,839 shares of LLY stock, worth $8.11 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

8,839

Previous 9,508 7.04%

Holding current value

$8.11 Million

Previous $7.4 Million 8.19%

% of portfolio

0.59%

Previous 0.53%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $484,938 - $608,147	-669 Reduced 7.04%	8,839 $8 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $296,100 - $396,140	500 Added 5.55%	9,508 $7.4 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $57,770 - $68,104	-110 Reduced 1.21%	9,008 $5.25 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $89,113 - $122,856	-205 Reduced 2.2%	9,118 $4.9 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $19,290 - $25,793	55 Added 0.59%	9,323 $4.37 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $259,376 - $304,624	835 Added 9.9%	9,268 $3.18 Million
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $41,158 - $47,957	128 Added 1.54%	8,433 $0
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.01%	8,305 $2.69 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $28,987 - $34,036	104 Added 1.27%	8,304 $2.69 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $47,172 - $58,623	201 Added 2.51%	8,200 $2.35 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $29,680 - $36,833	-132 Reduced 1.62%	7,999 $2.21 Million
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $7,041 - $9,108	-39 Reduced 0.48%	8,131 $1.87 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $9,037 - $11,699	-55 Reduced 0.67%	8,170 $1.53 Million
Q4 2020 Jan 12, 2021	SELL	$130.46 - $172.63 $3,261 - $4,315	-25 Reduced 0.3%	8,225 $1.39 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $189,623 - $228,210	-1,390 Reduced 14.42%	8,250 $1.35 Million
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $627,155 - $776,239	-5,268 Reduced 35.34%	9,640 $1.34 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $6,629 - $8,210	-62 Reduced 0.41%	14,908 $1.96 Million
Q1 2019 Apr 10, 2019	BUY	$111.31 - $131.02 $6,678 - $7,861	60 Added 0.4%	14,970 $1.94 Million
Q1 2018 Apr 13, 2018	BUY	$74.21 - $87.6 $28,941 - $34,164	390 Added 2.69%	14,910 $1.15 Million
Q4 2017 Jan 11, 2018	BUY	$81.94 - $87.89 $38,511 - $41,308	470 Added 3.35%	14,520 $1.23 Million
Q3 2017 Oct 06, 2017	BUY	$77.07 - $85.54 $1.08 Million - $1.2 Million	14,050	14,050 $1.2 Million

Others Institutions Holding LLY

# of Institutions

3,886

Shares Held

750M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $871B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.

Account

North Star Investment Management Corp. Eli Lilly & CO Transaction History